FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

119561000036107: Caprelsa (vandetanib 300 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2013. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3744191000168111 Caprelsa (vandetanib 300 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3744201000168114 Caprelsa 300 mg tablet en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caprelsa 300 mg tablet has manufactured dose form tablet true Inferred relationship Some
Caprelsa 300 mg tablet Is a trade product unit of use true Inferred relationship Some
Caprelsa 300 mg tablet Is a Caprelsa true Inferred relationship Some
Caprelsa 300 mg tablet Is a vandetanib 300 mg tablet true Inferred relationship Some
Caprelsa 300 mg tablet has manufactured dose form film-coated tablet false Inferred relationship Some
Caprelsa 300 mg tablet has unit of use tablet true Inferred relationship Some 1706143513
Caprelsa 300 mg tablet has Australian BoSS vandetanib true Inferred relationship Some 1706143512
Caprelsa 300 mg tablet has intended active ingredient vandetanib true Inferred relationship Some 1706143512

Inbound Relationships Type Active Source Characteristic Refinability Group
Caprelsa 300 mg tablet, 30, blister pack has TPUU True Caprelsa 300 mg tablet Inferred relationship Some 1
Caprelsa 300 mg tablet, 30 has TPUU True Caprelsa 300 mg tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start